Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG: 2252)

Market Cap	16.30B
Revenue (ttm)	167.86M
Net Income (ttm)	-806.22M
Shares Out	1.01B
EPS (ttm)	-0.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,919,870
Average Volume	11,485,801
Open	14.80
Previous Close	14.70
Day's Range	14.56 - 16.64
52-Week Range	6.03 - 16.74
Beta	1.19
RSI	84.07
Earnings Date	Mar 28, 2025

About Shanghai MicroPort MedBot (Group)

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People’s Republic of China. The company offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot fo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 646
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2252

Financial Performance

In 2023, Shanghai MicroPort MedBot (Group)'s revenue was 104.59 million, an increase of 384.15% compared to the previous year's 21.60 million. Losses were -1.01 billion, -11.20% less than in 2022.

Financial numbers in CNY